Yuehong Wu

871 citations
35 papers · 653 indexed · h-index 14
Topics
CRISPR and Genetic Engineering (6 papers)Pluripotent Stem Cells Research (6 papers)Animal Virus Infections Studies (4 papers)
Partner nations
ChinaUnited StatesFrance

In The Last Decade

Yuehong Wu

32 papers receiving 646 citations

Peers

Yuehong Wu
Comparison fields: 5 of 93
  • Molecular Biology 372
  • Immunology 93
  • Oncology 77
  • Pulmonary and Respiratory Medicine 70
  • Genetics 63
Replace Tetsuhisa Otani with:
Tetsuhisa Otani Japan
Paulo S. Ribeiro United Kingdom
Bowen Zhang China
Brandon M. Hall United States
Brad Lackford United States
Shusaku Shibutani Japan
Yimei Cai China
Heather A. Edens United States
Yuehong Wu relative to Tetsuhisa Otani Japan Tetsuhisa Otani's profile →
Citations per field
00.5×1.5×
Tetsuhisa Otani · 1×
Citations per year

Countries citing papers authored by Yuehong Wu

Since Specialization
Citations

This map shows the geographic impact of Yuehong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuehong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuehong Wu more than expected).

Fields of papers citing papers by Yuehong Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuehong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuehong Wu. The network helps show where Yuehong Wu may publish in the future.

Co-authorship network of co-authors of Yuehong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuehong Wu. A scholar is included among the top collaborators of Yuehong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuehong Wu. Yuehong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 4
5 0
6 6
7 6
8 10
9 26
10 12
11 15
12 4
13 31
14 25
15 31
16 1
17 97
18 142
19 11
20
Astudy on the efficacy and safety of Oselta mivir in the treatment of suspected influenza patients
1

About Yuehong Wu

Yuehong Wu is a scholar working on Biological Psychiatry, Microbiology and Gastroenterology, having authored 35 papers that have together received 653 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (6 papers), Pluripotent Stem Cells Research (6 papers) and Animal Virus Infections Studies (4 papers). The work is most often cited by research in Aging (46 citations), Biological Psychiatry (23 citations) and Microbiology (36 citations). Yuehong Wu has collaborated with scholars based in China, United States and France. Frequent co-authors include Peter J. Hornsby, James Mele, Sitai Liang, Rochelle Buffenstein, Wen‐Bin Ou, Suzette D. Tardif, Yulong He, Yong Zhang, Jianhong Shu and Quan He. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026